Harmonized Standards

USP participates in a number of international harmonization initiatives to improve global public health through the development of high quality public standards. USP works with pharmacopoeias, the World Health Organization, and other stakeholders to determine optimal ways to advance and sustain globally harmonized standards.

Currently, USP engages with our international partners in the following venues

  • Pharmacopeial Discussion Group (PDG): Formed in 1989, the PDG seeks to harmonize pharmacopeial standards (retrospective harmonization of excipient monographs and selected general chapters) between the USP, the European Pharmacopeia, and the Japanese Pharmacopeia through a formal, step wise process. The Indian Pharmacopoeia Commission (IPC) officially joined as a member in the PDG on October 2023.
  • Prospective Harmonization and Bilateral Agreements. Focused on creating harmonized monographs across multiple pharmacopoeias using submissions for sponsors in a collaborative fashion with partner pharmacopeias.
  • Adopt/Adapt Agreements: Started in the 1990’s, these agreements allow for the grant of rights to copy and adapt USP standards, allowing other pharmacopeias or regulatory authorities to incorporate USP standards into their own compendia as a means to promote harmonization or convergence toward harmonized standards.
  • WHO Good Pharmacopeial Practices (GPhP). Development of a common framework for the pharmacopeial standards-setting process (a guideline) in the context of the WHO’s International Meeting of World Pharmacopoeias, with the WHO Expert Committee on Specifications for Pharmaceutical Preparations overseeing the activity.
  • USP Exchange Programs: Sharing of scientific knowledge among global organizations involved in standards setting and the effective use of standards. The USP Visiting Scientist and Executive Exchange Programs (VSP and EEP) promote international harmonization of standards through the exchange of scientific staff and information with global collaborators and organizations committed to pharmacopeial advancement.

In addition, USP staff and volunteers provide topic-specific input into the standard-setting activities of the WHO International Pharmacopeia, the WHO Expert Committee on Biological Standardization and ICH working groups on quality topics.

Click here to read more

Strengthening Global Medicines Quality: USP’s New Role in Harmonization

Strengthening Global Medicines Quality: USP’s New Role in Harmonization

In the past three decades, an increasingly globalized medical marketplace has helped improve patient access to new medicines. Sadly, it has also provided an opportunity for more substandard, adulterated, and counterfeit medical products.

READ BLOG

Pharmacopoeial Harmonization: Focus on Japan

Pharmacopoeial Harmonization: Focus on Japan

While there are many pharmacopeias in the world, the goal of pharmacopeial harmonization is to achieve uniform public standards, which are truly representative of the global supply chain.

READ BLOG

Pharmacopeial Meeting Highlights

Pharmacopeial Meeting Highlights and News Releases

The USP, European Pharmacopoeia, Indian Pharmacopoeia Commission, and Japanese Pharmacopoeia convene twice a year to carry out the harmonization activities of the Pharmacopeial Discussion Group. Review highlights and news releases from the latest meetings.

REVIEW HIGHLIGHTS

Stage 4 Harmonization Notices

Stage 4 Harmonization Notices

View the latest standards to enter the final stage of the harmonization process.

View the latest Stage 4 notices

Stage 2 publications for public inquiry

Stage 2 publications for public inquiry

View the latest Stage 2 Proposals published in Phamacopeial Forum (PF).

View the latest Stage 2 proposals

PDG working procedures changes

PDG working procedures changes

View implementation of significant changes to the Pharmacopeial Discussion Group work structure.

Learn more